Rising Pharma Holding, Inc. is recalling 47,976 bottles of buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, a prescription medication used to treat depression. The recall was issued because foreign tablets or capsules from a different medication were found inside the 30-count bottles. No injuries or medical incidents have been reported to date regarding this issue.
Ingesting an incorrect medication from a prescription bottle could cause a patient to experience unintended side effects or fail to receive the therapeutic benefits of their prescribed treatment. Patients may be at risk if they consume a foreign tablet or capsule that was mistakenly packaged in the bottle.
You have 2 options:
Manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.